US Stem Cell Inc (USRM)

[Starbase9]

Yeah, I get that, but it has to be considered with the 150% prepayment penalties, how that fits into ongoing operational cash flows, and other specific terms in the notes.

The last two entries in February look like short term loans to meet weekly liquidity needs, just before their Phase I announcement results early March that gave them some breathing room.

It was well timed breathing room and I'm just wondering if that breathing room is enough for the short term... Again, it needs to be taken in as part of the complete cash flow picture. It seems as if 32K and 35K are significant sums at this point.

A big boost would be, perhaps in the next reports, to see a significant elimination of this financing. And much more "positive" detail on the MIRROR trials.